Interestingly, IL-1β was also found to activate the PI3K/Akt signaling pathway leading to the activation/nuclear translocation of NF-κB, further supporting the key role of this transcription factor as an effective molecular target for the treatment of tendinopathies [20, 21, 22]. Here, NFKB1 is linked to disease of the tendon.